家族性嗜铬细胞瘤诊治进展  

Progress in Diagnosis and Treatment of Familial Pheochromocytoma

作　　者：袁洋 张荣贵[1] 李俊伍 解晓都 闫九松 

机构地区：[1]重庆医科大学附属第二医院泌尿外科,重庆

出　　处：《临床医学进展》2023年第5期8020-8025,共6页Advances in Clinical Medicine

摘　　要：家族性嗜铬细胞瘤(Familial Pheochromocytoma, FP)是常染色体显性遗传病,家族性嗜铬细胞瘤可伴随某些遗传性综合征如:家族性视网膜及中枢性神经系统血管瘤病(Von-Hippel-Lindau disease,VHL病),多发内分泌肿瘤2型(MEN2),家族性副神经节瘤1~5型,神经纤维瘤病1型等,本文详细阐述了上述相关疾病与家族性嗜铬细胞瘤的相关性,对家族性嗜铬细胞瘤最新研究进展进行综述。Familial pheochromocytoma (FP) is an autosomal dominant disorder. Familial pheochromocytoma can be accompanied by certain genetic syndromes such as familial retinal and central nervous sys-tem angiomatosis (VHL disease), multiple endocrine neoplasia type 2 (MEN2), familial paragangli-oma type 1~5, neurofibromatosis type 1, and so on, This article describes in detail the correlation between the above related diseases and familial pheochromocytoma, and reviews the latest re-search progress in familial pheochromocytoma.

关 键 词：家族性嗜铬细胞瘤 多发内分泌肿瘤2型 VHL 

分 类 号：R73[医药卫生—肿瘤]